Related Experiment Videos
Antiplasmin: the forgotten serpin?
1Australian Centre for Blood Diseases, Monash University, Prahran. Paul.Coughlin@med.monash.edu.au
The FEBS Journal
|September 24, 2005
Summary
Antiplasmin, a serine protease inhibitor, regulates clot lysis through unique extensions. Its role in fibrinolysis is confirmed, highlighting its therapeutic potential.
Area of Science:
- Biochemistry
- Molecular Biology
- Hematology
Background:
- Antiplasmin is a serine protease inhibitor (serpin) with unique N- and C-terminal extensions.
- These extensions significantly modify its inhibitory activities compared to other serpins.
Purpose of the Study:
- To elucidate the biochemical mechanisms and physiological roles of antiplasmin.
- To investigate antiplasmin's function as a regulator of fibrinolysis and its therapeutic potential.
Main Methods:
- Biochemical characterization of antiplasmin's structure-function relationships.
- Analysis of antiplasmin's interaction with plasmin and its incorporation into clots.
- Utilizing genetically modified mouse models (targeted deletion) to study in vivo function.
Main Results:
- The N-terminus facilitates Factor XIIIa-mediated crosslinking and clot incorporation.
- Fibrin-bound antiplasmin is the primary regulator of clot lysis.
- The C-terminal region is crucial for rapid and efficient inhibition of plasmin.
Conclusions:
- Antiplasmin is a critical regulator of fibrinolysis, particularly in its fibrin-bound form.
- Genetic deletion studies confirm antiplasmin's essential role in regulating clot breakdown.
- Antiplasmin represents a significant therapeutic target for modulating coagulation and fibrinolysis.